Jeff Rosedale, Ph.D. is one of BakerHostetler’s most experienced IP partners, with more than 20 years as a registered U.S. patent lawyer and 10 years as an R&D chemical engineer. His areas of concentration include developing IP strategies and international patent portfolios for many early-stage companies covering a wide variety of technical areas, including the life sciences, advanced materials and consumer products.
Jeff has also negotiated numerous license agreements on behalf of clients and routinely provides strategic patent prosecution guidance and patent diligence advice in connection with high value transactions. In view of his breadth of experience, he is a partner in both of our Patent Prosecution Groups, for Biotechnology, Chemical and Pharmaceutical Patent Prosecution as well as for Electrical, Mechanical and Computer Science.
Jeff works at the cutting edge of science and technology to develop and protect clients’ intellectual property. He helps clients, including many startups and early-stage companies, draft IP-critical agreements such as licenses, joint-development agreements and joint-venture agreements. He also works with clients to develop IP strategies, patent portfolios and licensing strategies, utilizing his extensive technical background. Similarly, Jeff advises venture capital and private equity firms by providing critical evaluations of the IP portfolios of their target investments.
A frequent lecturer on IP and a frequently cited author, Jeff is well versed in the trends and nuances of multiple industries, including biotechnology, pharmaceuticals, medical devices, nanotechnology, advanced materials, 3-D printing, electronics, augmented reality / virtual reality (AR/VR), artificial intelligence and computer science. Through his many outreach activities with students, scientists, engineers and business professionals at the local and national levels, Jeff maintains a strong network throughout the innovation infrastructure of the U.S.